Novel Pulmonary Hypertension Drug Proves Safe, Effective

After a year of being treated with a novel drug, Riociguat, patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH), and those with persistent or recurrent pulmonary hypertension after an operation for the disease, showed sustained improvement.